BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34094840)

  • 1. Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas.
    Schoedel K; Miller V; Osei-Hwedieh D; Watters R; Duensing A; John I; Chandran U; Chang A; Soman V; Weiss K
    J Bone Oncol; 2021 Aug; 29():100370. PubMed ID: 34094840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
    Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
    Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report.
    Huang J; Jiang Z; Yang Q; Zhang H
    Int J Surg Pathol; 2013 Feb; 21(1):48-53. PubMed ID: 22736299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response.
    Singh A; Thorpe SW; Darrow M; Carr-Ascher JR
    Front Oncol; 2022; 12():991724. PubMed ID: 36465334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
    Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
    World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMPR2-pSMAD1/5 signaling pathway regulates RUNX2 expression and impacts the progression of dedifferentiated chondrosarcoma.
    Yang K; Tang XD; Guo W; Xu XL; Ren TT; Ren CM; Wang SD; Bao X; Zhang F; Sun KK
    Am J Cancer Res; 2016; 6(6):1302-16. PubMed ID: 27429845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
    Xu X; Tang X; Guo W; Yang K; Ren T
    Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonality analysis and
    Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
    J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
    Delling G; Welkerling H
    Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.
    Zając W; Dróżdż J; Kisielewska W; Karwowska W; Dudzisz-Śledź M; Zając AE; Borkowska A; Szumera-Ciećkiewicz A; Szostakowski B; Rutkowski P; Czarnecka AM
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
    Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
    Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
    Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
    Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy.
    Schoedel K; Heim T; Duensing A; Lohse I; Presutti L; Belayneh R; Bhogal S; Singh-Varma A; Chang A; Chandran U; Marker D; Szabo-Rogers H; Weiss K
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
    van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
    Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
    Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
    Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.